SBIR TOPIC 081: ADJUVANT DEVELOPMENT FOR VACCINES AGAINST INFECTIOUS OR IMMUNE-MEDIATED DISEASES
$600,000
| Recipient | ANTAGEN BIOSCIENCES INC UEI HXD6EFH2ND57 |
|---|---|
| Award ID | 75N93020C00042 |
| Award amount | $600,000 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN12 |
| Set-aside | Unrestricted |
| Start date | Sep 1, 2020 |
| End date | Aug 31, 2022 |
| Place of performance | BOSTON, MA |
| Record updated | May 27, 2022 |
View the official award record
More awards won by ANTAGEN BIOSCIENCES INC
THE OBJECTIVE OF THIS CONTRACT IS TO USE IMMUNOGENS (ENVS) COMBINED WITH EFFECTIVE MULTIVALENT ANTIGENIC DISPLAY ON NANOPARTICLES (NPS) FOR DELIVERY TO PROMOTE STRONG AND LONG-LIVED NEUTRALIZING ANTIBODY RESPONSES AGAINST HIV AND DIRECT AFFINITY MATURATION TOWARD HIV NEUTRALIZING ANTIBODIES.
Department of Health and Human Services · $599,914 · Jun 17, 2019
AWARD TO ANTAGEN PHARMACEUTICALS
Department of Health and Human Services · $300,000 · Jul 5, 2022
THE GOAL OF THE PROPOSED PROJECT IS TO FURTHER DEVELOP ANTAGEN'S NOVEL PROTEIN NANOPARTICLE-BASED EXPRESSION AND DELIVERY SYSTEM USING FCRIDER TECHNOLOGY AND ANTIBODY AFUCOSYLATION TECHNOLOGY TO PRODUCE A2,6-SIALYLATED AFUCOSYLATED ENV-FCRIDER (
Department of Health and Human Services · $299,998 · Jul 1, 2022
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids